Pediatric hypermobility spectrum disorders (pgHSD) represent a complex group of multisystemic heritable connective tissue disorders. Clinicians often under-recognize these conditions in pediatric populations because early symptoms appear vague. Consequently, children experience significant diagnostic delays and prolonged morbidity. However, understanding the clustering of symptoms can lead to much earlier intervention and better management.

A recent scoping review identifies eight recurring symptom clusters that characterize early pgHSD. These clusters include frequent joint subluxations, chronic musculoskeletal pain, and disabling fatigue. Additionally, many patients experience orthostatic intolerance and various gastrointestinal complaints. Interestingly, impaired neurodevelopmental traits also appear frequently in these pediatric patients. Therefore, healthcare providers must look beyond joint flexibility to recognize the full clinical picture.

Improving Recognition of Pediatric Hypermobility Spectrum Disorders

Early clinical recognition remains a primary challenge because many symptoms mimic common childhood ailments. For example, growing pains or general fatigue might mask the underlying connective tissue issue. Moreover, the absence of definitive genetic markers for many forms of hypermobility necessitates a clinical diagnosis based on these identified clusters. By focusing on the co-occurrence of pain, fatigue, and autonomic dysfunction, clinicians can identify at-risk children sooner.

Furthermore, the multi-system involvement suggests that a holistic approach to care is absolutely necessary. Specialists across different fields should coordinate to address the various manifestations of the disorder. Therefore, pediatricians and rheumatologists should remain vigilant when these specific symptom clusters occur together in young patients.

What are the most common symptoms of pgHSD?

The most common symptoms include joint subluxations, chronic musculoskeletal pain, disabling fatigue, and gastrointestinal issues.

Why is early diagnosis of pgHSD important?

Early diagnosis prevents prolonged morbidity and ensures that children receive appropriate multidisciplinary care before complications become severe.

How do neurodevelopmental traits relate to hypermobility?

Recent studies show that children with hypermobility frequently exhibit neurodevelopmental traits, though the exact mechanisms linking these conditions are still under investigation.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Pochcial P et al. Age-related symptom clustering in pediatric hypermobility spectrum disorders: a scoping review. Orphanet J Rare Dis. 2026 May 30. doi: 10.1186/s13023-026-04424-0. PMID: 42218552.

Tinkle B, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017;175(1):48-69.

Engelbert RH, et al. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017;175(1):158-167.